RT Journal Article
SR Electronic
T1 ▾ Xamoterol - more trouble than it’s worth?
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 53
OP 54
DO 10.1136/dtb.28.14.53
VO 28
IS 14
YR 1990
UL http://dtb.bmj.com/content/28/14/53.abstract
AB Xamoterol (Corwin - ICI) is a selective β1, adrenoceptor partial agonist which was at first promoted for the treatment of chronic heart failure, except in severe cases. In May the Committee on Safety of Medicines (CSM) and the manufacturer recommended much more restricted use1 and as we went to press it was being suggested in the media that the drug should be withdrawn. We here discuss whether it should be used or not.